Pharmaceuticals

Phenobarbital Market Growth Patterns And Forecast Outlook Through 2030

May 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Phenobarbital Market Compare Between 2026 And 2030?

The phenobarbital market has shown consistent expansion in recent years. Its size is expected to increase from $1.54 billion in 2025 to $1.62 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.9%. The market’s past growth was driven by its enduring clinical effectiveness, broad inclusion in essential medicine lists, the high occurrence of epilepsy, its application in neonatal intensive care, and its more affordable price point compared to newer treatments.

The phenobarbital market size is projected to experience consistent growth in the coming years, with expectations to reach $1.96 billion by 2030, progressing at a compound annual growth rate (CAGR) of 5.0%. This anticipated expansion over the forecast period is fueled by several factors, including sustained demand in low-resource settings, the broadening of generic manufacturing, an increase in neonatal intensive care units, rising rates of epilepsy diagnosis, and a concentrated effort on ensuring access to essential medicines. Prominent trends for the forecast period involve the drug’s continued application in managing epilepsy and neonatal seizures, an expanding availability of generic phenobarbital, an increasing emphasis on cost-effective anticonvulsant therapies, the growth of hospital-based seizure management services, and enhanced monitoring of long-term drug safety.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24377&type=smp

What Key Factors Are Shaping The Phenobarbital Market Landscape?

The phenobarbital market is expected to expand due to the rising prevalence of epilepsy, a neurological disorder marked by recurrent, unprovoked seizures originating from abnormal electrical activity in the brain. This increase in epilepsy cases is largely attributed to greater awareness, prompting more individuals to recognize symptoms and seek medical diagnosis, thereby leading to higher reported instances. Phenobarbital is effective for epilepsy as it functions as an anticonvulsant medication that slows down the activity of brain neurons, aiding in seizure prevention and control. For example, in February 2024, the World Health Organization, a Switzerland-based international public health agency, indicated that around 50 million people globally were living with epilepsy, reinforcing its position as one of the most common neurological diseases worldwide. Consequently, the growing prevalence of epilepsy is anticipated to propel the growth of the phenobarbital market.

Which Segment Classifications Are Used In The Phenobarbital Market Segment Analysis?

The phenobarbital market covered in this report is segmented –

1) By Indication: Epilepsy, Neonatal Seizures

2) By Dosage Forms: Tablets, Capsules, Injectables

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

4) By Application: Seizure Management, Anesthesia, Sleep Disorders, Alcohol Withdrawal Syndrome

5) By End User: Hospitals, Clinics, Research Laboratories, Homecare Settings

Subsegments:

1) By Epilepsy: Focal (Partial) Seizures, Generalized Tonic-Clonic Seizures, Status Epilepticus, Refractory Epilepsy, Idiopathic Epilepsy

2) By Neonatal Seizures: Hypoxic-Ischemic Encephalopathy (HIE)-Induced Seizures, Intracranial Hemorrhage-Induced Seizures, Metabolic Disorders, Congenital Brain Malformations, Infections

Which Trends Are Impacting The Progress Of The Phenobarbital Market?

Leading companies operating in the phenobarbital market are focusing on developing innovative solutions, such as phenobarbital sodium, to enhance the effectiveness and safety of treatments. Phenobarbital sodium refers to the sodium salt form of phenobarbital, a medication primarily used as an anticonvulsant and sedative. It is commonly prescribed to manage seizures, particularly in conditions such as epilepsy, as well as to treat anxiety and insomnia and sometimes to induce sedation before medical procedures. For instance, in January 2023, Sun Pharmaceutical Industries Ltd., an India-based pharmaceutical company, launched SEZABY (phenobarbital sodium) in the U.S., the first and only FDA-approved medication specifically indicated for treating seizures in both term and preterm neonates. This new formulation is benzyl alcohol-free and propylene glycol-free, making it safer for use in newborns. SEZABY received orphan drug designation and is backed by clinical data showing it effectively controls neonatal seizures, addressing a critical unmet need in this vulnerable patient population.

Which Firms Are Contributing To The Phenobarbital Market Ecosystem?

Major companies operating in the phenobarbital market are Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Fresenius Kabi AG, Baxter International Inc., Par Pharmaceutical Inc., Harman Finochem Ltd., Manus Aktteva Biopharma LLP, Shandong Xinhua Pharmaceutical Co. Ltd., Alkaloida Chemical Company Zrt., Yashiro Pharmaceutical Co. Ltd., JPN Pharma Pvt. Ltd., Pfizer CentreOne, Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Zydus Lifesciences Ltd., Aurobindo Pharma Ltd.

Get The Full Phenobarbital Market Report:

https://www.thebusinessresearchcompany.com/report/phenobarbital-global-market-report

Which Region Is The Top Contributor To The Phenobarbital Market By Share?

North America was the largest region in the phenobarbital market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the phenobarbital market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Phenobarbital Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/phenobarbital-global-market-report

Browse Through More Reports Similar to the Global Phenobarbital Market 2026, By The Business Research Company

Phenolic Panel Market Report 2026

https://www.thebusinessresearchcompany.com/report/phenolic-panel-global-market-report

Phosgene Market Report 2026

https://www.thebusinessresearchcompany.com/report/phosgene-global-market-report

Anticholinergic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/anticholinergic-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795